Cosmetic salt
The disulfide bond in hair is restored through thiol-reactive crosslinking agent, which solves the problem of damage during hair treatment, achieves improvement in hair quality and strength, and provides effective hair care effects.
Patent Information
- Application Number
- CN202380031405.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-04
- Filing Date
- 2023-04-04
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is difficult to effectively avoid or repair damage during hair treatment, especially due to disulfide bond breaks caused by chemicals and physical treatments, resulting in a decrease in hair quality, strength and texture.
A thiol-reactive crosslinking agent has been developed to restore disulfide bonds in hair by physical or chemical crosslinking, and to use specific salts and cosmetic preparations as hair care products to enhance the recovery effect of hair.
Effectively restore and enhance the disulfide bonds of hair, improve the quality, strength and texture of hair, reduce damage during treatment, and provide better hair care results.
Smart Images

Figure CN118973997A_ABST
Abstract
Description
[0001] Public domain The present disclosure relates to salts and cosmetic preparations thereof, and their use as hair care products. Further disclosed is a method for treating keratin materials, such as hair.
[0002] Public background Human hair has a highly organized but complex structure. It consists of a follicle embedded in the skin and a hair shaft that protrudes outside the skin. Hair usually consists of two or three layers. The outermost layer is the stratum corneum, the middle layer is the cortex, and in some cases, there is a central medullary region consisting of concentrated cells and / or cavities. Most of the mass of human hair consists of fiber structures called macrofibrils, each of which is composed of microfibrils bound together by matrix proteins. Proteins account for 65-95% of the weight of human hair, and the predominant keratin is a fibrous helical protein that is particularly rich in the amino acid cysteine, whose sulfhydryl groups can form disulfide crosslinks, adding rigidity and resistance to the overall hair structure.
[0003] There are various treatments for hair, such as bleaching, dyeing, straightening and permanent curling, during which the hair may become over-treated or damaged due to the chemicals required to achieve the desired changes. For example, some known hair straightening processes consist of treatment with alkaline straightening agents. The high pH (9.0-14.0) causes the hair to swell, which allows the alkaline agent to penetrate into the hair fiber, where it reacts with the keratin and causes the disulfide bonds present in the keratin to break and rearrange, causing the hair to be stretched. In addition to the damage caused by chemicals, physical treatments such as frequent and / or high temperature (handling) or environmental exposure may also produce changes in the texture of the hair and cause further damage that is usually permanent.
[0004] Public Overview It would be highly desirable to be able to avoid, minimize, reduce or repair any such damage that occurs during those hair treatment processes, and in particular to be able to restore disulfide bonds to restore and improve hair quality, strength and texture.
[0005] It is an object of the present disclosure to advance the state of the art in hair repair. It is another object of the present disclosure to provide salts and formulations for use as hair care products, which are preferably capable of crosslinking thiol moieties. The thiol moieties to be crosslinked can be formed, for example, by the cleavage of disulfide bonds produced by physical or chemical hair treatments. It is another object of the present disclosure to enhance the restoration of disulfide bonds in hair using the linkers of the present invention.
[0006] Applicants have developed thiol-reactive cross-linking agents that are capable of cross-linking thiol moieties, thereby mimicking disulfide bonds. The thiol moieties to be cross-linked can, for example, result from prior cleavage of disulfide bonds (e.g., resulting from physical or chemical hair treatments). By cross-linking thiol moieties, the thiol-reactive cross-linking agents disclosed herein effectively achieve restoration of disulfide bonds.
[0007] In a first aspect, the present disclosure relates to salts of formula I in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - and a diallyl ammonium group, where R 5 Independently selected from H, straight or branched C 1-6 alkyl; L is a straight chain C 1-15 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR 1 -Substitution, where R 1 Is it a straight chain or branched chain C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
[0008] In some embodiments, the present disclosure relates to salts of Formula II in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2- 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2, C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; M is selected from O, S, NH and NR 1 , where R 1 Is it a straight chain or branched chain C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
[0009] In some embodiments of the salt of Formula I or Formula II, the diallyl ammonium group is a moiety of Formula D1 or Formula D2 Where R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl.
[0010] In some embodiments of the salt of Formula I or Formula II, G is selected from R 5 C≡C-CO2 - , R 5 C≡CC(=O)S - , R 5 C≡C-CS2 - , R 5 C≡C-SO2 - , R 5 C≡CS(=O)S - , R 5 C≡C-SO3 -, R 5 C≡CS(=O)2S - and (CH2=CH2CH2) i NR 4 r + , where i is selected from 2 and 3, r is selected so that the sum of i and r is 4, R 5 Each occurrence is independently selected from H, straight or branched C 1-6 Alkyl, and R 4 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I or Formula II, G is selected from R 5 C≡C-CO2 - and (CH2=CH2CH2) i NH (4-i) + , wherein i is selected from 2 and 3, R 5 Selected from H, straight chain or branched C 1-6 In some embodiments of the salt of Formula I or Formula II, G is selected from HC≡C-CO2 and (CH2=CH2CH2)2NH2 + .
[0011] In some embodiments, the present disclosure relates to salts of formula III in M is selected from O, S and NR 6 , where R 6 Selected from H, straight chain or branched C 1-6 alkyl; R 5 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
[0012] In some embodiments of the salt of Formula III, R 5 is H, and M is O.
[0013] In some embodiments of the salt of formula III, m and n are independently selected from 2 or 3. In preferred embodiments of the salt of formula III, m and n are both selected from 2 or 3.
[0014] In some embodiments, the present disclosure relates to salts of Formula IV in M is selected from O, S and NR 6 , where R6 Selected from H, straight chain or branched chain C 1-6 alkyl; R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
[0015] In some embodiments of the salt of Formula IV, R 4 is H, and M is O.
[0016] In some embodiments of the salt of Formula IV, m and n are independently selected from 1 and 2.
[0017] In some embodiments of the salt of formula II, formula III or formula IV, m is equal to n. In some embodiments of the salt of formula II, formula III or formula IV, m is equal to n, and x is equal to y. In some embodiments of the salt of formula II, formula III or formula IV, m is equal to n, and x is different from y.
[0018] In a second aspect, the present disclosure relates to a cosmetic formulation comprising at least one salt according to any of the embodiments described herein.
[0019] In some embodiments of the cosmetic preparation, the cosmetic preparation further comprises at least one cosmetic additive selected from the group consisting of surfactants, oil components, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithin, phospholipids, UV protection factors, moisturizers, biogenic agents, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, tanning agents, tyrosine inhibitors (depigmenting agents), hydrotropes, solubilizers, preservatives, fragrance oils and dyes, and mixtures thereof.
[0020] In some embodiments of the cosmetic preparation, a carrier is further included, preferably a carrier selected from water, C(2-6)-alcohol, C(1-10) polyol and oil component.
[0021] In a third aspect, the present disclosure relates to a salt, a composition or a cosmetic formulation according to any of the embodiments described herein for use as a hair care product.
[0022] In a fourth aspect, the present disclosure relates to the use of a salt according to any of the embodiments described herein for the production of a cosmetic formulation, preferably a hair care product.
[0023] In a fifth aspect, the present disclosure relates to a method for treating a keratin material (eg, hair), the method comprising applying to the keratin material a salt or a cosmetic formulation according to any of the embodiments described herein.
[0024] The salts and cosmetic preparations disclosed herein are suitable for cosmetic uses, and are particularly useful for protecting healthy hair or improving damaged hair.
[0025] Public details In the context of the present disclosure, restoration of a disulfide bond refers to the process by which two sulfhydryl moieties are linked together (it should be understood that the term "disulfide bond" refers to two sulfhydryl moieties linked using the salts of the present invention rather than a directly linked -SS- bond). The sulfhydryl moieties can be, for example, part of keratin. The process of linking the sulfhydryl moieties together can involve the reaction of each sulfhydryl with an electrophilic moiety in a crosslinking agent. The sulfhydryl-reactive crosslinking agents disclosed herein typically react with two sulfhydryl moieties to form a crosslinking unit that links the two sulfhydryl moieties together.
[0026] Unless otherwise indicated, the following general definitions apply to all salts of the present disclosure according to the present specification.
[0027] As used herein, the term "salts of the present disclosure" refers to salts represented by Formulas I-IV and any specific examples disclosed herein.
[0028] It is to be understood that "independently of each other" means that when a group occurs more than one time in any salt, its definition on each occurrence is independent of any other occurrence.
[0029] It should be further understood that a dashed line or a solid line without a connection (e.g., -C 1-4 Alkyl) depicts the position of attachment of the residue (ie, partial chemical formula).
[0030] It should be further understood that the abbreviations "C" and "N" represent all possible saturations that generally do not generate free radicals, nitrenes or carbenes, i.e., N includes -NH-, -N= and C includes -CH2-, ==CH- and In addition, "C" as an atom in an aromatic ring or a heteroaromatic ring having a substituent Rx at any suitable position includes =CH- and =CR x -. In addition, "C" means that there is no substituent R at any appropriate position. x The atoms in the aromatic or heteroaromatic ring of include ==CH- and Those skilled in the art understand and appreciate that general rules of valency must be followed.
[0031] It is to be understood that in any formula, whenever a straight or branched alkyl chain (e.g., a straight or branched C 1-15When more than one CH2 group of an alkyl group (e.g., an alkyl group) is replaced by a heteroatom or a group containing a heteroatom, two or more CH2 groups are replaced in such a way that heteroatoms are not directly adjacent (e.g., -OO- or -NH-NH-). In particular, two or more CH2 groups should be replaced in such a way that the alkyl chain does not contain peroxide groups. The same is true for the selection of a universal group (e.g., L) as defined herein, which is selected in such a way that heteroatoms are not directly adjacent (e.g., -OO- or -NH-NH-).
[0032] The term "diallylammonium group" refers to a positively charged nitrogen atom covalently bonded to four substituents, wherein at least two of the four substituents are allyl substituents. Examples of "diallylammonium groups" include (CH2=CHCH2)2NR2 + 、(CH2=CHCH2)3NR + 、(CH2=CHCH2)4N + 、(CH2=C(CH3)CH2)2NR2 + 、(CH2=C(CH3)CH2)3NR + 、(CH2=C(CH3)CH2)4N + 、((CH3)HC=CCH2)2NR2 + 、((CH3)HC=CCH2)3NR + 、((CH3)HC=CCH2)4N + 、((CH3)2C=CCH2)2NR2 + 、((CH3)2C=CCH2)3NR + 、((CH3)2C=CCH2)4N + , wherein R can be independently selected from H and straight or branched C 1-6 In some embodiments, a "diallyl ammonium group" refers to a positively charged nitrogen atom covalently bonded to four substituents, two of which are allylic substituents and the other two are not allylic substituents. In some embodiments, a "diallyl ammonium group" is (CH2=CHCH2)2NR2 + , wherein R can be independently selected from H and straight or branched C 1-6 In some embodiments, the "diallyl ammonium group" is (CH2=CHCH2)2NH2 + .
[0033] When both E and Z isomers exist (eg, in the crotyl fragment ((CH3)HC=CCH2-)), both the E and Z isomers and any mixtures thereof are included.
[0034] An "allyl substituent" or "allyl" refers to a -CH2CH=CH2 unit which may be optionally substituted with one or more C 1-6 Alkyl substitution. Examples of "allyl" include -CH2CH=CH2, -CH(CH3)CH=CH2, -C(CH3)2CH=CH2 units, -CH2C(Me)=CH2, -CH2CH=CH(CH3)(E and Z), -CH2CH=C(CH3)2. In some embodiments, "allyl" is -CH2CH=CH2.
[0035] The term "C 1-14 Alkyl", "C 1-12 Alkyl", "C 1-11 Alkyl" and "C 1-6 "Alkyl" refers to a fully saturated branched or unbranched hydrocarbon moiety having the specified number of carbon atoms. 1-14 Representative examples of alkyl include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, neohexyl, heptyl, octyl, nonyl, decyl, dodecyl, and the like. 1-6 Representative examples of alkyl include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, or neohexyl. 1-14 Alkyl, C 1-12 Alkyl, C 1-11 Alkyl and C 1-6 One or more adjacent or non-adjacent CH2 groups of the alkyl group are independently replaced by one or more groups selected from the group consisting of: -(CH2-O-CH2)-, -(CH2-CH2-O)-, and -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, -NR-, wherein R is a linear or branched C 1-6 alkyl.
[0036] As used herein, certain parameters (e.g., p and q) refer to charge. Charge can be, for example, 2+, +, - or 2-. 2+ refers to two positive charges, i.e., the corresponding ion carries two positive charges. On the contrary, 2- refers to two negative charges, i.e., the corresponding ion carries two negative charges. Charge generally refers to an ion, which can be an entire chemical part or fragment or entity. The charge of an ion refers to the total charge of the ion, which can be calculated by adding all the positive and negative charges contained in the ion. As an example, the total charge of an ion comprising an ammonium group and two carboxylates will be -. The charge of an ion can be delocalized on more than one atom. The charge can also be localized on a small number of atoms (e.g., one atom).
[0037] Based on the definitions given throughout this application, a person skilled in the art knows which combinations are synthetically feasible and realistic, for example, combinations that result in some heteroatoms being directly linked to each other (e.g., -OO-) are generally not considered, however, synthetically feasible combinations are considered, such as -SN= in isothiazole.
[0038] In a first aspect, the present disclosure relates to salts of formula I in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - and a diallyl ammonium group, where R 5 Independently selected from H, straight or branched C 1-6 alkyl; L is a straight chain C 1-15 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR 1 -Substitution, where R 1 Is it a straight chain or branched chain C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 32. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
[0039] In some embodiments of the salt of Formula I, q is +. In some embodiments of the salt of Formula I, q is -.
[0040] In some embodiments of the salt of formula I, p is 2+. In some embodiments of the salt of formula I, p is +. In some embodiments of the salt of formula I, p is 2-. In some embodiments of the salt of formula I, p is -.
[0041] In some embodiments of the salt of Formula I, g is 1. In some embodiments of the salt of Formula I, g is 2.
[0042] In some embodiments of the salts of Formula I, q is +, p is -, and g is 1. In some embodiments of the salts of Formula I, q is +, p is 2-, and g is 2. In some embodiments of the salts of Formula I, q is -, p is +, and g is 1. In some embodiments of the salts of Formula I, q is -, p is 2+, and g is 2.
[0043] In some embodiments of the salt of Formula I, G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - and a diallyl ammonium group, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 -and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, G is selected from R 5 -C≡C-CO2 - and a diallyl ammonium group, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, G is selected from R 5 -C≡C-CO2 - and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, G is selected from HC≡C-CO2 - and (CH2=CH-CH2) i NH (4-i) + , wherein i is independently selected from 2 and 3.
[0044] In some embodiments of the salt of Formula I, q is +, and G is a diallyl ammonium group. In some embodiments of the salt of Formula I, q is +, and G is (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, q is +, and G is (CH2=CH-CH2) i NH (4-i) + , wherein i is independently selected from 2 and 3. In the embodiments described in this paragraph, preferably, p is -, and g is 1.
[0045] In some embodiments of the salt of Formula I, q is -, and G is selected from R 5 -C≡C-CO2 - , R5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - , where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, q is -, and G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, q is -, and G is R 5 -C≡C-CO2 - , where R 5 Independently selected from H, straight or branched C 1-6 In the embodiments described in this paragraph, preferably, p is 2+ and g is 2.
[0046] In some embodiments of the salt of Formula I, L is a linear C 1-10 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR1-, wherein R 1 Is it a straight chain or branched chain C 1-6 In some embodiments of the salt of Formula I, L is a linear C 1-10 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, or -S-. In some embodiments of the salt of Formula I, L is a linear C 1-10 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, or -O-.
[0047] In some embodiments of the salt of Formula I, A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, p is + or 2+, and A is NR 2 3 + , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, p is - or 2-, and A is CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, p is - or 2-, and A is selected from CO2 - 、C(=O)S - , CS2 - In some embodiments of the salt of Formula I, p is - or 2-, and A is CO2 - .
[0048] In some embodiments of the salt of Formula I, E is selected from NR 3 2. NR33 + , CO2H, C(=O)SH, CS2H, CO2 - 、C(=O)S - , CS2 - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula I, E is selected from NR 3 2. NR 3 3 + ,CO2H,CO2 - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl.
[0049] In some embodiments of the salt of Formula I, q is +; p is - or 2-; g is 1 or 2; G is a diallyl ammonium group; L is a straight chain C 1-15 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR 1 -Substitution, where R 1 Is it a straight chain or branched chain C 1-6 alkyl; A is selected from CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - ; E is selected from NR 3 2. CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
[0050] In some embodiments of the salt of Formula I, q is -; p is 2+ or +; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5-C≡CS(=O)2S - , where R 5 Independently selected from H, straight or branched C 1-6 Alkyl; L is a straight chain C 1-15 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR 1 -Substitution, where R 1 is a straight chain or branched C1-6 alkyl group; A is NR 2 3 + , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, S02H, S(=O)SH, SO3H, S(=O)2SH, among which R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
[0051] In some embodiments, the salts of the present invention have Formula II in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - and (CH2=CH-CH2) i NR 4 (4-i)+ , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2, C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; M is selected from O, S, NH and NR 1 , where R 1 Is it a straight chain or branched chain C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula II is neutral.
[0052] In some embodiments of the salt of Formula II, q is +. In some embodiments of the salt of Formula II, q is -.
[0053] In some embodiments of the salt of Formula II, p is 2+. In some embodiments of the salt of Formula II, p is +. In some embodiments of the salt of Formula II, p is 2-. In some embodiments of the salt of Formula II, p is -.
[0054] In some embodiments of the salt of Formula II, g is 1. In some embodiments of the salt of Formula II, g is 2.
[0055] In some embodiments of the salt of Formula II, q is +, p is -, and g is 1. In some embodiments of the salt of Formula II, q is +, p is 2-, and g is 2. In some embodiments of the salt of Formula II, q is -, p is +, and g is 1. In some embodiments of the salt of Formula II, q is -, p is 2+, and g is 2.
[0056] In some embodiments of the salt of Formula II, G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, G is selected from R 5 -C≡C-CO2 - and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 Alkyl, where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, G is selected from R 5 -C≡C-CO2 - and (CH2=CH-CH2) i NH (4-i) + , wherein i is independently selected from 2 and 3, wherein R 5 Independently selected from H, straight or branched C 1-6 alkyl.
[0057] In some embodiments of the salt of Formula II, q is +, and G is (CH2=CH-CH2) i NR 4 (4-i) +, wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, q is +, and G is (CH2=CH-CH2) i NH (4-i) + , wherein i is independently selected from 2 and 3. In the embodiments described in this paragraph, preferably, p is -, and g is 1.
[0058] In some embodiments of the salt of Formula II, q is -, and G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - , where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, q is -, and G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , where R 5 Independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, q is -, and G is R 5 -C≡C-CO2 - , where R 5 Independently selected from H, straight or branched C 1-6 In the embodiments described in this paragraph, preferably, p is 2+ and g is 2.
[0059] In some embodiments of the salt of formula II, m and n are both selected from 1, 2, and 3. In some embodiments of the salt of formula II, m and n are 1. In some embodiments of the salt of formula II, m and n are 2. In some embodiments of the salt of formula II, m and n are 3.
[0060] In some embodiments of the salt of Formula II, x and y are both selected from 0, 1, and 2. In some embodiments of the salt of Formula II, x and y are both 0. In some embodiments of the salt of Formula II, x and y are both 1. In some embodiments of the salt of Formula II, x and y are both 2. In some embodiments of the salt of Formula II, x is 0, and y is 1.
[0061] In some embodiments of the salt of Formula II, A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, p is + or 2+, and A is NR 2 3 + , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, p is - or 2-, and A is CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, p is - or 2-, and A is selected from CO2 - 、C(=O)S - , CS2 - In some embodiments of the salt of Formula II, p is - or 2-, and A is CO2 - .
[0062] In some embodiments of the salt of Formula II, E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, CO2 - 、C(=O)S - , CS2 - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 In some embodiments of the salt of Formula II, E is selected from NR 3 2. NR 3 3 +,CO2H,CO2 - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl.
[0063] In some embodiments of the salt of Formula II, q is +; p is - or 2-; g is 1 or 2; G is (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 alkyl; A is selected from CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 3 2. CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; M is selected from O, S, NH and NR 1 , where R 1 Is it a straight chain or branched chain C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula II is neutral.
[0064] In some embodiments of the salt of Formula II, q is -; p is 2+ or +; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - , where R 5 Independently selected from H, straight or branched C 1-6 Alkyl; A is NR 2 3 + , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, among which R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; M is selected from O, S, NH and NR 1 , where R 1 Is it a straight chain or branched chain C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula II is neutral.
[0065] In some embodiments of any of the salts disclosed herein, the diallyl ammonium group is a moiety of formula d1 or formula d2 Where R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl.
[0066] In some embodiments of any of the salts disclosed herein, the diallyl ammonium group has formula d1 or formula d2, wherein R4 It's H.
[0067] In some embodiments of any of the salts disclosed herein, the diallyl ammonium group is a moiety of formula d1. In some embodiments of any of the salts disclosed herein, the diallyl ammonium group is a moiety of formula d2.
[0068] In some embodiments of the salts disclosed herein, the ion containing the diallyl ammonium group is (CH2=CHCH2)2NH2 + .
[0069] In some embodiments, the salts of the invention have the formula III in M is selected from O, S and NR 6 , where R 6 Selected from H, straight chain or branched chain C 1-6 alkyl; R 5 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
[0070] In some embodiments of the salt of formula III, M is O. In some embodiments of the salt of formula III, M is S. In some embodiments of the salt of formula III, M is NR 6 , where R 6 Selected from H, straight chain or branched chain C 1-6 alkyl.
[0071] In some embodiments of the salt of Formula III, R 5 is H. In some embodiments of the salt of Formula III, R 5 Is it a straight chain or branched chain C 1-6 alkyl.
[0072] In some embodiments of the salt of formula III, x and y are independently selected from 0 and 1. In some embodiments of the salt of formula III, x and y are selected from 0, 1 and 2. In some embodiments of the salt of formula III, x and y are selected from 0 and 1. In some embodiments of the salt of formula III, x and y are 0. In some embodiments of the salt of formula III, x and y are 1. In some embodiments of the salt of formula III, x is 0 and y is 1.
[0073] In some embodiments of the salt of formula III, m and n are independently selected from 2 and 3. In some embodiments of the salt of formula III, m and n are selected from 1, 2, and 3. In some embodiments of the salt of formula III, m and n are selected from 2 and 3. In some embodiments of the salt of formula III, m and n are 2. In some embodiments of the salt of formula III, m and n are 3.
[0074] In some embodiments of the salt of formula III, m and n are 2, and x and y are 0. In some embodiments of the salt of formula III, m and n are 3, and x and y are 1. In some embodiments of the salt of formula III, m and n are 2, x is 0, and y is 1. In some embodiments of the salt of formula III, m and n are 3, x is 0, and y is 1.
[0075] In some embodiments of the salt of formula III, M is O, m and n are 2, and x and y are 0. In some embodiments of the salt of formula III, M is O, m and n are 3, and x and y are 1. In some embodiments of the salt of formula III, M is O, m and n are 2, x is 0, and y is 1. In some embodiments of the salt of formula III, M is O, m and n are 3, x is 0, and y is 1.
[0076] In some embodiments, the salts of the invention have Formula IV in M is selected from O, S and NR 6 , where R 6 Selected from H, straight chain or branched chain C 1-6 alkyl; R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
[0077] In some embodiments of the salt of formula III, M is O. In some embodiments of the salt of formula III, M is S. In some embodiments of the salt of formula III, M is NR 6 , where R 6 Selected from H, straight chain or branched chain C 1-6 alkyl.
[0078] In some embodiments of the salt of Formula III, R 4 Each occurrence is H. In some embodiments of the salt of Formula III, R 4 Each occurrence is a straight or branched chain C 1-6 Alkyl, for example methyl, ethyl or n-propyl, especially methyl.
[0079] In some embodiments of the salt of Formula IV, m and n are independently selected from 1 and 2. In some embodiments of the salt of Formula IV, m and n are selected from 1, 2, and 3. In some embodiments of the salt of Formula IV, m and n are selected from 1 and 2. In some embodiments of the salt of Formula IV, m and n are 1. In some embodiments of the salt of Formula IV, m and n are 2.
[0080] In some embodiments of the salt of Formula IV, x and y are independently selected from 0 and 1. In some embodiments of the salt of Formula IV, x and y are selected from 0, 1, and 2. In some embodiments of the salt of Formula IV, x and y are selected from 0 and 1. In some embodiments of the salt of Formula IV, x and y are 0. In some embodiments of the salt of Formula IV, x and y are 1. In some embodiments of the salt of Formula IV, x is 0 and y is 1.
[0081] In some embodiments of the salt of formula IV, m and n are 1, and x and y are 1. In some embodiments of the salt of formula IV, m and n are 1, and x and y are 0. In some embodiments of the salt of formula IV, m and n are 2, and x and y are 1.
[0082] In some embodiments of the salt of Formula IV, M is O, m and n are 1, and x and y are 1. In some embodiments of the salt of Formula IV, M is O, m and n are 1, and x and y are 0. In some embodiments of the salt of Formula IV, M is O, m and n are 2, and x and y are 1.
[0083] In further specific embodiments, the present disclosure relates to the specific examples disclosed in Table 1. SPC-TB-0015 SPC-TB-0016 SPC-TB-0017 SPC-TB-0018 SPC-TB-0019 SPC-TB-0020 Table 1
[0084] Salts of the present disclosure may contain one or more asymmetric centers in the molecule. Salts of unspecified stereochemistry should be understood to include all optical isomers (e.g., diastereomers, enantiomers, etc.) in pure or substantially pure form, as well as mixtures thereof (e.g., racemic mixtures or enantiomerically enriched mixtures). It is well known in the art how to prepare such optically active forms (e.g., by resolving racemic forms via recrystallization techniques, by synthesis from optically active raw materials, by chiral synthesis, by chromatographic separation using chiral stationary phases, and other methods).
[0085] The salt may be an isotopically labeled compound, such as a compound comprising various isotopes of hydrogen, carbon, nitrogen, oxygen. The disclosed salts may exist as tautomers, and mixtures and separate single tautomers are contemplated. In addition, some salts may exhibit polymorphism.
[0086] The salts of the present disclosure may exist in a solid, i.e., crystalline (e.g., polymorphs, i.e., different crystalline structures having the same chemical composition but different in packing, geometric arrangement) or non-crystalline form (optionally as solvates), or liquid. In the solid state, it may exist in a mixture or as a mixture thereof. In a crystalline solvate, solvent molecules are incorporated into the crystal lattice during crystallization. The formation of solvates may include non-aqueous solvents, such as, but not limited to, ethanol, isopropanol, DMSO, acetic acid, ethanolamine, or ethyl acetate; or aqueous solvents, such as water (also referred to as "hydrates"). Different polymorphs may be produced, for example, by changing or adjusting reaction conditions or reagents.
[0087] In another aspect, the present disclosure also provides methods for preparing the salts of Formula I-IV of the present disclosure.
[0088] In yet another aspect, the present disclosure further provides cosmetic formulations comprising an effective amount of one or more salts of the present disclosure and one or more pharmaceutically acceptable carriers and / or excipients (also referred to as diluents). An excipient is acceptable in the sense that it is compatible with the other ingredients of the formulation and not deleterious to the recipient thereof. As used herein, the term "effective amount" refers to an amount of the salt of the present disclosure (either by itself or in the form of a cosmetic formulation) that is effective for producing the desired effect of hair repair.
[0089] Typically, the pH of cosmetic preparations is 3.5 to 6, in particular 4 to 5, at 20° C. The pH can be adjusted, for example, using lactic acid, citric acid, and the like.
[0090] Typically, the concentration of the salts disclosed herein will be between 0.01% and 5% by weight of the cosmetic formulation, for example 2% to 4% by weight. In some embodiments, the concentration of the salts disclosed herein is 50-130 mmol / L of the cosmetic formulation, especially 80-100 mmol / L.
[0091] In some embodiments, the cosmetic formulation comprises a solubilizer. The concentration of the solubilizer may be, for example, 5% to 20% by weight of the cosmetic formulation, in particular 10% to 20%, such as 15% to 20%.
[0092] In some embodiments, the cosmetic formulation comprises phenoxyethanol in a concentration of 0.1% to 1.7% by weight of the cosmetic formulation, in particular 0.7% to 1.1%, such as 0.9%.
[0093] In some embodiments, the cosmetic formulation comprises ethylhexylglycerin in a concentration of 0.01% to 0.2%, in particular 0.08% to 0.12%, such as 0.1%, by weight of the cosmetic formulation.
[0094] As used herein, the phrase "pharmaceutically acceptable carrier" means a pharmaceutically acceptable material, composition or vehicle, such as a liquid or solid filler, diluent, excipient, manufacturing aid (e.g., lubricant, talc, magnesium, calcium or zinc stearate, or stearic acid); or a solvent encapsulating material, which is involved in carrying or transporting the subject salt or compound from one organ or part of the body to another. Each carrier must be "acceptable" in the sense of being compatible with the other ingredients of the formulation and not injurious to the person being treated. Some examples of materials that can serve as pharmaceutically acceptable carriers include: (1) sugars such as lactose, glucose, and sucrose; (2) starches such as corn starch and potato starch; (3) cellulose and its derivatives such as sodium carboxymethylcellulose, ethylcellulose, and cellulose acetate; (4) tragacanth powder; (5) malt; (6) gelatin; (7) talc; (8) excipients such as cocoa butter and suppository waxes; (9) oils such as peanut oil, cottonseed oil, safflower oil, sesame oil, olive oil, corn oil, and soybean oil; (10) dibasic Alcohols, such as propylene glycol; (11) polyols, such as glycerol, sorbitol, mannitol and polyethylene glycol; (12) esters, such as ethyl oleate and ethyl laurate; (13) agar; (14) buffers, such as magnesium hydroxide and aluminum hydroxide; (15) alginic acid; (16) pyrogen-free water; (17) isotonic saline; (18) Ringer's solution; (19) ethanol; (20) pH buffered solutions; (21) polyesters, polycarbonates and / or polyanhydrides; and (22) other non-toxic compatible substances used in cosmetic formulations.
[0095] Such compositions may contain other ingredients conventional in cosmetic preparations, such as wetting agents, emulsifiers and lubricants, such as sodium lauryl sulfate and magnesium stearate; as well as colorants, release agents, coating agents, sweeteners, flavoring agents and fragrances, preservatives and antioxidants, pH adjusters, fillers and other active agents. Examples of pharmaceutically acceptable antioxidants include: (1) water-soluble antioxidants, such as ascorbic acid, cysteine hydrochloride, sodium bisulfate, sodium metabisulfite, sodium sulfite, etc.; (2) oil-soluble antioxidants, such as ascorbyl palmitate, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), lecithin, propyl gallate, α-tocopherol, etc.; and (3) metal chelators, such as citric acid, ethylenediaminetetraacetic acid (EDTA), sorbitol, tartaric acid, phosphoric acid, etc.
[0096] Such compositions can be prepared by any method known in the art, for example by combining the active ingredient with one or more carriers and / or excipients. Different compositions and examples of carriers and / or excipients are well known to those skilled in the art and are described in detail, for example, in the following documents: Remington: The Science and Practice of Pharmacy. Pharmaceutical Press, 201 3; Rowe, Sheskey, Quinn: Handbook of Pharmaceutical Excipients. Pharmaceutical Press, 2009. Excipients that can be used in the preparation of cosmetic formulations can include one or more of the following to provide a composition or formulation suitable for selected administration: buffers, stabilizers, surfactants, wetting agents, lubricants, emulsifiers, suspending agents, preservatives, antioxidants, opacifiers, glidants, processing aids, colorants, sweeteners, fragrances, flavoring agents, diluents, and other known additives.
[0097] The cosmetic preparations of the present disclosure may be in any suitable form. In some embodiments, such suitable forms include, but are not limited to, liquids, such as liquids of low to medium viscosity, such as lotions, milks, mousses, sprays, gels, creams, ointments, pastes, and the like. Depending on the form of use of the preparation (e.g., lotions, gels, ointments, or creams), suitable excipients (e.g., those listed above) are included or excluded from the skin preparation.
[0098] The liquid form of the salt of the present disclosure includes pharmaceutically acceptable emulsions, microemulsions, solutions, suspensions, syrups and elixirs. In addition to the active ingredient, the liquid form can also contain inert diluents commonly used in the art, such as water or other solvents, solubilizers and emulsifiers, such as ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol, oil (especially cottonseed oil, peanut oil, corn oil, germ oil, olive oil, castor oil and sesame oil), glycerol, tetrahydrofuran alcohol, polyethylene glycol and fatty acid esters of sorbitan, and mixtures thereof. In the form of suspensions, the salt can contain suspending agents, such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol and sorbitan esters, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar and tragacanth gum, and mixtures thereof.
[0099] The salt or compound may be mixed under sterile conditions with a pharmaceutically acceptable carrier and any preservatives, buffers or propellants that may be required in the form of a spray, ointment, paste, cream, lotion, gel, solution. In addition to the salts of the present disclosure, such ointments, pastes, creams and gels may contain excipients such as animal and vegetable fats, oils, waxes, paraffins, starches, tragacanth, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicic acid, talc and zinc oxide, or mixtures thereof.
[0100] In the form of powders and sprays, the salts of the present disclosure may contain excipients such as lactose, talc, silicic acid, aluminum hydroxide, calcium silicate and polyamide powder or mixtures of these substances. Sprays may additionally contain customary propellants such as chlorofluorocarbons and volatile unsubstituted hydrocarbons (e.g., butane and propane).
[0101] In some embodiments, the cosmetic formulation is a hair care product, which includes products in the form of shampoos, conditioners, hair masks, hair rinses, hair sprays, hair foams, hair mousses, hair gels, hair tonics, and the like.
[0102] It should be understood that all contemplated compositions and formulations must be stable under the conditions of manufacture and storage and must be preserved against the contaminating action of microorganisms such as bacteria and fungi.
[0103] The amount of the salt of the present disclosure in the cosmetic formulation of the present disclosure can be adjusted so as to obtain an amount of the salt of the present disclosure that is effective to achieve the desired cosmetic response for a particular person, composition, and mode of administration without being harmful to the person. The amount selected will depend on a variety of factors, including the nature of the specific salt of the present disclosure used, the route of administration, the time of administration, the duration of the treatment, other compounds, salts, and / or materials used in combination with the specific salt, the age, sex, weight, condition, general health and previous medical history of the person being treated, and similar factors well known in the medical field.
[0104] Generally, a suitable amount of the salt of the present disclosure will be the amount of salt that is the minimum amount effective to produce the desired effect. Such an effective dose will generally depend on the factors described above. In the form of a shampoo, the amount of the cosmetic preparation applied per treatment may be, for example, 1 g-10 g. In the form of a conditioner and / or a hair mask, the amount of the cosmetic preparation applied per treatment may be, for example, 1 g-10 g. In the form of a leave-in conditioner or a leave-in hair mask, the amount of the cosmetic preparation applied per treatment may be, for example, 0.1 g-7 g.
[0105] According to the present disclosure, all salts, compositions, formulations and / or methods disclosed and claimed herein can be prepared and implemented without undue experimentation. It will be apparent to those skilled in the art that the present disclosure may be varied without departing from the scope of the present disclosure. The embodiments provided herein are intended to be illustrative and non-exhaustive; therefore, the illustrated embodiments should not be considered to limit the present disclosure in any way. Example Material: N-Cbz-cysteine is obtained by reducing its cysteine counterpart via a method known from the literature (Adv. Syn. Catal., 2020, 362, 5093-5104. DOI: 10.1002 / adsc.202000716). " "N°0 Intensive Bond Building Hair Treatment" is a commercially available product comprising active agent, water, phenoxyethanol and sodium benzoate. The active agent is hereinafter labeled as "Olaplex active agent".
[0107] Example 1: Synthesis of Olaplex Active Agent The active agent "Olaplex Active" used as a reference compound in Example 8 has the following structure: It is synthesized by reacting 2 equivalents of the corresponding acid with 1 equivalent of the corresponding diamine.
[0108] Example 2: Synthesis of Salt 15 (SPC-TB-0015) (a) SPC-TB-0015 To a solution of 2,2'-oxybis(ethyl-1-amine) (100 mg, 1.0 eq, 0.96 mmol) in DCM (1.92 mL) was added propiolic acid (134 mg, 2.0 eq., 1.92 mmol). After 2 h reaction time, the solvent was concentrated to give the resulting salt (235 mg, quant.) as an orange oil.
[0109] 1 H NMR (400MHz, DMSO) 68.29 (m, 6H), 3.59 (dd, J=5.6Hz, 4.4Hz, 4H), 3.16 (m, 2H), 2.97 (dd, J=5.6Hz, 4.4Hz, 4H).
[0110] Example 3: Synthesis of Salt 16 (SPC-TB-0016) (a) SPC-TB-0016 To a solution of 3,3′-((oxybis(ethane-2,1-diyl))bis(oxy))bis(propan-1-amine) (500 mg, 1.0 eq, 2.27 mmol) in DCM (4.54 mL) was added propiolic acid (318 mg, 2.0 eq., 4.53 mmol). After 2 h reaction time, the solvent was concentrated to give the resulting salt (818 mg, quantitative) as an orange oil.
[0111] 1 H NMR (400MHz, DMSO) 68.08 (s, 6H), 3.55-3.42 (m, 12H), 2.99 (s, 2H), 2.87-2.76 (m, 4H), 1.78 (p, J=8.0, 6.2Hz, 4H).
[0112] Example 4: Synthesis of Salt 17 (SPC-TB-0017) (a) SPC-TB-0017 To a solution of 2,2′-((oxybis(ethane-2,1-diyl))bis(oxy))diacetic acid (5.000 g, 1 Eq, 22.50 mmol) in MeCN (24.46 ml) was slowly added diallylamine (2.186 g, 2.78 mL, 1 Eq, 22.50 mmol) at room temperature. The solution was stirred at room temperature for 2 h. The solvent was removed under reduced pressure to give the resulting salt (7.179 g, 22.48 mmol, 99.90%) as a yellow oil.
[0113] 1 H NMR (400MHz, DMSO) δ9.03 (s, 2H), 5.87 (ddt, J=16.8, 10.4, 6.3Hz, 2H), 5.35-5.17 (m, 4H) , 3.88 (s, J=1.5Hz, 4H), 3.54 (dddt, J=7.8, 5.8, 4.2, 2.1Hz, 8H), 3.30 (d, J=20.1Hz, 5H).
[0114] Example 5: Synthesis of Salt 18 (SPC-TB-0018) (a) SPC-TB-0018 According to the 15g scale, modify the steps: 2,2'-oxydiacetic acid (15.0 g, 1 Eq, 112 mmol) was suspended in MeCN (122 mL) at room temperature. Diallylamine (10.9 g, 13.8 mL, 1 Eq, 112 mmol) was added dropwise (at this time point, all the material was dissolved), and the solution was stirred at room temperature for 1 h. The solvent was concentrated to obtain the resulting salt (25.9 g, quantitative) as an off-white solid.
[0115] 1 H NMR (400MHz, DMSO) 65.35 (m, 2H), 5.40 (m, 4H), 3.93 (s, 4H), 3.53 (d, J = 2.7Hz, 4H).
[0116] Example 6: Synthesis of Salt 19 (SPC-TB-0019) (a) SPC-TB-0019 To a solution of 3,3′-((oxybis(ethane-2,1-diyl))bis(oxy))dipropionic acid (400 mg, 1.0 eq, 1.60 mmol) in DCM (16.0 mL) was added diallylamine (311 mg, 2.0 eq., 3.20 mmol). After 2 h reaction time, the solvent was concentrated to give the resulting salt (580 mg, quantitative) as a colorless oil.
[0117] 1 H NMR (400MHz, DMSO) 65.82 (m, 2H), 5.12 (m, 4H), 3.59 (t, J=6.4Hz, 4H), 3.15 (m, 4H), 2.42 (t, J=6.4Hz, 4H).
[0118] Example 7: Synthesis of Salt 20 (SPC-TB-0020) (a) SPC-TB-0020 To a solution of 2,2′-(ethane-1,2-diylbis(oxy)bis(ethyl-1-amine) (5.00 g, 1.00 Eq, 34.0 mmol) in DCM (14.0 mL) at 0°C was added propiolic acid (4.20 mL, 2.00 Eq, 67.0 mmol) in DCM (14.0 mL) pre-cooled to 0°C. Caution: highly exothermic reaction, add very slowly. The reaction mixture was stirred at 0°C for 15 min and allowed to warm to room temperature for 1 h. It was concentrated under reduced pressure to give an orange oil (quantitative yield).
[0119] 1 H NMR (400MHz, DMSO) δ3.63-3.56 (m, 8H), 3.04 (s, 2H), 2.95 (t, J=5.4Hz, 4H).
[0120] Example 8: Thiol Rebinding General steps The compound to be tested (1 eq.) was dissolved in an aqueous medium (0.02 M), and 4 eq. of a cysteine reagent (N-Cbz-cysteine) was added. Phosphate buffer (pH = 5.4) was used as the aqueous medium.
[0121] To prepare phosphate buffer, prepare 0.1 M citric acid solution (using citric acid monohydrate) and 0.2 M Na2HPO4 solution (using Na2HPO4 or Na2HPO4*2H2O) and mix in the following ratio: 44.25 mL / 55.75 mL=mL 0.1 M citric acid / mL 0.2 M Na2HPO4 to obtain a buffer solution with pH=5.4.
[0122] The tests were performed in LC-MS vials or glass vials at an ambient temperature of 30°C under stirring with a small magnetic stirrer. The reactions were performed under standard atmospheric pressure. The reactions were monitored by LC-MS. The reaction scale was between 4 mg and 10 mg of the tested compound. To calculate the conversion to product, the ratios between the cysteine reagent, the corresponding monoadduct (mono) and the bisadduct (bis) as shown in the following scheme were compared.
[0123] The tested compounds showed improved reactivity with cysteine derivatives compared to Olaplex actives.
[0124] result Test compound 30min conversion rate 60min conversion rate 5h conversion rate Olaplex Actives 4% Double 7% Double 18% Double SPC-TB-0015* 12% Double SPC-TB-00 1 8* 15% Double *Conversion was evaluated after dilution of the reaction mixture with MeCN.
Claims
1. A salt of formula I in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - and a diallyl ammonium group, where R 5 Independently selected from H, straight or branched C 1-6 alkyl; L is a straight chain C 1-15 Alkyl, wherein one or more CH2 groups are independently replaced by -(CH2-O-CH2)-, -(CH2-CH2-O)-, -(O-CH2-CH2)-, C=O, -O-, -S-, -NH-, or -NR 1 -Substitution, where R 1 Is it a straight chain or branched chain C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - and S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight chain or branched C1-6 alkyl; E is selected from NR 3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2- 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
2. The salt according to claim 1, which has the formula II in q is + or -; p is 2+, +, - or 2-; g is 1 or 2; G is selected from R 5 -C≡C-CO2 - , R 5 -C≡CC(=O)S - , R 5 -C≡C-CS2 - , R 5 -C≡C-SO2 - , R 5 -C≡CS(=O)S - , R 5 -C≡C-SO3 - , R 5 -C≡CS(=O)2S - , where R 5 Independently selected from H, straight or branched C 1-6 Alkyl, and (CH2=CH-CH2) i NR 4 (4-i) + , wherein i is independently selected from 2 and 3, wherein R 4 Independently selected from H, straight or branched C 1-6 alkyl; A is selected from NR 2 3 + 、CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 2 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; E is selected from NR3 2. NR 3 3 + , CO2H, C(=O)SH, CS2H, SO2H, S(=O)SH, SO3H, S(=O)2SH, CO2 - 、C(=O)S - , CS2 - 、SO2 - 、S(=O)S - 、SO3 - 、S(=O)2S - , where R 3 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; M is selected from O, S, NH and NR 1 , where R 1 Is it a straight chain or branched chain C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2; Provided that the total charge of A and E is not zero, and provided that the total charge of the salt of Formula I is neutral.
3. The salt according to claim 1 or 2, wherein the diallyl ammonium group is a part of formula d1 or formula d2, Where R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl.
4. The salt according to claim 1, which has the formula III in M is selected from O, S and NR 6 , where R 6 Selected from H, straight chain or branched chain C 1-6 alkyl; R 5 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
5. The salt according to claim 4, wherein R 5 is H, and M is O.
6. The salt according to claim 4 or 5, wherein m and n are independently selected from 2 or 3, wherein preferably, m and n are both selected from 2 or 3.
7. The salt according to claim 1, which has the formula IV in M is selected from O, S and NR 6 , wherein R6 is selected from H, straight chain or branched C 1-6 alkyl; R 4 Each occurrence is independently selected from H, straight or branched C 1-6 alkyl; m and n are independently selected from 1, 2 and 3; x and y are independently selected from 0, 1 and 2.
8. The salt according to claim 7, wherein R4 is H and M is O.
9. The salt according to claim 87 or 8, wherein m and n are independently selected from 1 and 2.
10. The salt according to any one of claims 2 to 9, wherein m is equal to n, and optionally, x is equal to y.
11. Cosmetic preparation comprising at least one salt according to any one of the preceding claims.
12. The cosmetic preparation according to claim 11, further comprising at least one cosmetic additive selected from the group consisting of surfactants, oil components, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithin, phospholipids, UV protection factors, moisturizers, biogenic agents, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, tanning agents, tyrosine inhibitors (depigmenting agents), hydrotropes, solubilizers, preservatives, fragrance oils and dyes, and mixtures thereof.
13. The cosmetic preparation according to any one of claims 11 to 12, further comprising a carrier, preferably a carrier selected from water, C(2-6)-alcohols, C(1-10) polyols, and oil components.
14. Use of a salt according to any one of claims 1 to 10 for producing a cosmetic preparation, preferably a hair care product.
15. Method for treating keratin materials such as hair, said method comprising applying to said keratin materials a salt according to any one of claims 1 to 10 or a cosmetic preparation according to any one of claims 11 to 13.
